Pubertal timing, tempo and growth through puberty in children with hypophosphataemic rickets: a single-centre retrospective cohort study

Background Children with hypophosphataemic rickets (HR) remain short despite conventional treatment. It is still debated when height is lost, and pubertal timing and tempo have rarely been compared with population references. We compared both with Turkish references and described growth through puberty in children with HR of mixed aetiology. Methods This exploratory retrospective single-centre study included 33 children with HR first seen in 1994–2025. Ages at pubertal onset (breast stage 2 or testicular volume ≥ 4 mL; interval-censored analysis of all patients) and at menarche were compared with Turkish references. Height standard deviation scores (SDS) across pubertal stages were analysed with a linear mixed model, excluding growth hormone-treated children. Results Mean onset age was 9.68 years in girls and 9.75 years in boys; the differences from the reference were − 0.42 years (95% confidence interval [CI] − 1.25 to 0.38) and − 1.85 years (− 2.86 to − 0.86). Menarche (n = 10, mostly whole-year ages) was 0.95 years (0.40 to 1.49) later than the reference, mainly in girls first seen after onset. In five girls followed from before puberty, the difference in age at menarche was + 0.48 years (− 0.32 to 1.28), and their mean interval from breast stage 2 to menarche was at least 2.80 years (difference from the reference + 1.00 years, − 0.47 to 2.47). In 12 patients with ≥ 2 measurements from stage 2 onwards, height SDS fell by 0.82 (0.44 to 1.19) between stage 2 and near-final height (NFH), yet the five measured at both points gained 14.2–32.4 cm, within or above the reference range. NFH was − 2.88 ± 1.56 SDS (mean ± standard deviation; n = 12) and 1.70 SDS (0.58 to 2.82) below target height (n = 8). Conclusions Pubertal onset was not delayed and may be early in boys; a slower tempo in girls needs confirmation. In this small cohort, height SDS fell through puberty despite height gains in centimetres within or above the reference range, and NFH remained well below target height.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11599339/v1
Primary Topic
Hypothalamic control of reproductive hormones
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pubertal timing, tempo and growth through puberty in children with hypophosphataemic rickets: a single-centre retrospective cohort study

Şükran Poyrazoğlu, Firdevs Baş, Tuğçe Kandemir, Melek Yıldız et al.
Research Square
Hypothalamic control of reproductive hormones
preprint

Pubertal timing, tempo and growth through puberty in children with hypophosphataemic rickets: a single-centre retrospective cohort study

Şükran Poyrazoğlu, Firdevs Baş, Tuğçe Kandemir, Melek Yıldız, Feyza Darendelıler, Aslı Derya Kardelen, Cansu Koç, Ozge Bayrak Demirel
preprint en

Abstract

Background Children with hypophosphataemic rickets (HR) remain short despite conventional treatment. It is still debated when height is lost, and pubertal timing and tempo have rarely been compared with population references. We compared both with Turkish references and described growth through puberty in children with HR of mixed aetiology. Methods This exploratory retrospective single-centre study included 33 children with HR first seen in 1994–2025. Ages at pubertal onset (breast stage 2 or testicular volume ≥ 4 mL; interval-censored analysis of all patients) and at menarche were compared with Turkish references. Height standard deviation scores (SDS) across pubertal stages were analysed with a linear mixed model, excluding growth hormone-treated children. Results Mean onset age was 9.68 years in girls and 9.75 years in boys; the differences from the reference were − 0.42 years (95% confidence interval [CI] − 1.25 to 0.38) and − 1.85 years (− 2.86 to − 0.86). Menarche (n = 10, mostly whole-year ages) was 0.95 years (0.40 to 1.49) later than the reference, mainly in girls first seen after onset. In five girls followed from before puberty, the difference in age at menarche was + 0.48 years (− 0.32 to 1.28), and their mean interval from breast stage 2 to menarche was at least 2.80 years (difference from the reference + 1.00 years, − 0.47 to 2.47). In 12 patients with ≥ 2 measurements from stage 2 onwards, height SDS fell by 0.82 (0.44 to 1.19) between stage 2 and near-final height (NFH), yet the five measured at both points gained 14.2–32.4 cm, within or above the reference range. NFH was − 2.88 ± 1.56 SDS (mean ± standard deviation; n = 12) and 1.70 SDS (0.58 to 2.82) below target height (n = 8). Conclusions Pubertal onset was not delayed and may be early in boys; a slower tempo in girls needs confirmation. In this small cohort, height SDS fell through puberty despite height gains in centimetres within or above the reference range, and NFH remained well below target height.

Research Square
Istanbul University (TR)
Hypothalamic control of reproductive hormones
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon